Notice of Cancelation

In light of developments with COVID-19, we have made the decision to cancel the International Regulators’ Roundtable on Artificial Intelligence Technologies in Health Care.

Conference Description

Join us as we bring together federal-level government regulators of artificial intelligence technologies in North American, European, and Asian jurisdictions to highlight efforts around the globe to appropriately regulate the use of artificial intelligence (AI) technologies in health care. The assembled regulators will discuss their initiatives in this area along with the challenges of regulating this unique and rapidly developing field. Uniquely among AI-focused events, this conference will concentrate on the hurdles to implementing effective regulation of these new technologies and to consider the role of government regulators in shaping the evolution of AI in health care.

Interdisciplinary panels of regulators, legal scholars, regulatory science experts, physicians, and AI developers will articulate the challenges and opportunities in this space. These panels will foster cross-disciplinary discussion and improve public understanding of the state of AI implementation in health care, including highlighting regulatory leaders.

Agenda

8:30 – 9:00am, Registration

9:00 – 9:15am, Introductions

9:15 – 9:30am, Welcome Remarks

9:30 – 10:00am, Keynote

10:00 – 11:00am, Panel 1: The Potential, Promise, and Pitfalls of Health AI

11:00 – 11:15am, Break

11:15am – 12:15pm, Panel 2: Legal Considerations in Regulating Health AI

• Moderator: Nicholson Price, Professor of Law, University of Michigan School of Law

12:15 – 12:45pm, Keynote

12:45 – 1:15pm, Lunch

1:15 – 2:30pm, Panel 3: Is AI Different Than Other New Technologies?

2:30 – 3:30pm, Panel 4: Good Governance of Health AI

3:30 – 3:45pm, Break

3:45 – 4:45pm, Panel 5: Challenges and Opportunities of Regulating AI

---

Sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, the Centre for Advanced Studies in Biomedical Innovation Law at University of Copenhagen, with support from the Jorcks Foundation Research Prize, and the Massachusetts Institute of Technology Institute for Medical Engineering and Science.

Part of the Precision Medicine, Artificial Intelligence, and the Law Project at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, which is supported by a Novo Nordisk Foundation-grant for a Collaborative Research Programme (grant agreement number NNF17SA0027784).